April 10 (Reuters) - Shuttle Pharmaceuticals Holdings Inc SHPH.O:
SHUTTLE PHARMACEUTICALS- FILES PROVISIONAL PATENT APPLICATION FOR PSMA LIGAND CONJUGATES TO TREAT PROSTATE CANCER
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.